BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 31467228)

  • 21. PSF/SFPQ is a very common gene fusion partner in TFE3 rearrangement-associated perivascular epithelioid cell tumors (PEComas) and melanotic Xp11 translocation renal cancers: clinicopathologic, immunohistochemical, and molecular characteristics suggesting classification as a distinct entity.
    Rao Q; Shen Q; Xia QY; Wang ZY; Liu B; Shi SS; Shi QL; Yin HL; Wu B; Ye SB; Li L; Chen JY; Pan MH; Li Q; Li R; Wang X; Zhang RS; Yu B; Ma HH; Lu ZF; Zhou XJ
    Am J Surg Pathol; 2015 Sep; 39(9):1181-96. PubMed ID: 26274027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alveolar soft part sarcoma: a bimarker diagnostic strategy using TFE3 immunoassay and ASPL-TFE3 fusion transcripts in paraffin-embedded tumor tissues.
    Pang LJ; Chang B; Zou H; Qi Y; Jiang JF; Li HA; Hu WH; Chen YZ; Liu CX; Zhang WJ; Li F
    Diagn Mol Pathol; 2008 Dec; 17(4):245-52. PubMed ID: 18382356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expanding the molecular signatures of malignant ossifying fibromyxoid tumours with two novel gene fusions: PHF1::FOXR1 and PHF1::FOXR2.
    Srivastava P; Zilla ML; Naous R; Marker D; Khoshnoodi P; Burgess M; Herradura A; Wu J; Surrey LF; John I
    Histopathology; 2023 May; 82(6):946-952. PubMed ID: 36648026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary malignant ossifying fibromyxoid tumour of the bone. A clinicopathologic and molecular report of two cases.
    Sbaraglia M; Bellan E; Gambarotti M; Righi A; Zanatta L; Toffolatti L; Dei Tos AP
    Pathologica; 2020 Dec; 112(4):184-190. PubMed ID: 33179613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification by FFPE RNA-Seq of a new recurrent inversion leading to RBM10-TFE3 fusion in renal cell carcinoma with subtle TFE3 break-apart FISH pattern.
    Just PA; Letourneur F; Pouliquen C; Dome F; Audebourg A; Biquet P; Vidaud M; Terris B; Sibony M; Pasmant E
    Genes Chromosomes Cancer; 2016 Jun; 55(6):541-8. PubMed ID: 26998913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Detection of ASPL-TFE3 fusion gene by reverse transcriptase polymerase chain reaction in paraffin-embedded tumor tissues of alveolar soft part sarcoma].
    Pang LJ; Li F; Chang B; Hu WH; Lu TC; Li XX; Li HA; Jiang JF
    Zhonghua Bing Li Xue Za Zhi; 2004 Dec; 33(6):508-12. PubMed ID: 15634444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epithelioid hemangioendotheliomas with TFE3 gene translocations are compossible with CAMTA1 gene rearrangements.
    Lee SJ; Yang WI; Chung WS; Kim SK
    Oncotarget; 2016 Feb; 7(7):7480-8. PubMed ID: 26840265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Melanotic Xp11 translocation renal cancer: a case with PSF-TFE3 gene fusion and up-regulation of melanogenetic transcripts.
    Chang IW; Huang HY; Sung MT
    Am J Surg Pathol; 2009 Dec; 33(12):1894-901. PubMed ID: 19809274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alveolar soft part sarcoma of lung: report of a unique case with emphasis on diagnostic utility of molecular genetic analysis for TFE3 gene rearrangement and immunohistochemistry for TFE3 antigen expression.
    Zhao M; Rao Q; Wu C; Zhao Z; He X; Ru G
    Diagn Pathol; 2015 Sep; 10():160. PubMed ID: 26369552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular characterization of epithelioid haemangioendotheliomas identifies novel WWTR1-CAMTA1 fusion variants.
    Patel NR; Salim AA; Sayeed H; Sarabia SF; Hollingsworth F; Warren M; Jakacky J; Tanas M; Oliveira AM; Rubin BP; Lazar AJ; López-Terrada D; Wang WL
    Histopathology; 2015 Nov; 67(5):699-708. PubMed ID: 25817592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Technique for differentiating alveolar soft part sarcoma from other tumors in paraffin-embedded tissue: comparison of immunohistochemistry for TFE3 and CD147 and of reverse transcription polymerase chain reaction for ASPSCR1-TFE3 fusion transcript.
    Tsuji K; Ishikawa Y; Imamura T
    Hum Pathol; 2012 Mar; 43(3):356-63. PubMed ID: 21835426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fusion of the genes BRD8 and PHF1 in endometrial stromal sarcoma.
    Micci F; Brunetti M; Dal Cin P; Nucci MR; Gorunova L; Heim S; Panagopoulos I
    Genes Chromosomes Cancer; 2017 Dec; 56(12):841-845. PubMed ID: 28758277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PHF1 rearrangements in ossifying fibromyxoid tumors of soft parts: A fluorescence in situ hybridization study of 41 cases with emphasis on the malignant variant.
    Graham RP; Weiss SW; Sukov WR; Goldblum JR; Billings SD; Dotlic S; Folpe AL
    Am J Surg Pathol; 2013 Nov; 37(11):1751-5. PubMed ID: 23887158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mammalian target of rapamycin pathway activity in alveolar soft part sarcoma.
    Reis H; Hager T; Wohlschlaeger J; Bauer S; Katenkamp K; Katenkamp D; Baba HA
    Hum Pathol; 2013 Oct; 44(10):2266-74. PubMed ID: 23871289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TFE3 activation in a TSC1-altered malignant PEComa: challenging the dichotomy of the underlying pathogenic mechanisms.
    Schmiester M; Dolnik A; Kornak U; Pfitzner B; Hummel M; Treue D; Hartmann A; Agaimy A; Weyerer V; Lekaj A; Brakemeier S; Peters R; Öllinger R; Märdian S; Bullinger L; Striefler JK; Flörcken A
    J Pathol Clin Res; 2021 Jan; 7(1):3-9. PubMed ID: 33180365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel fusion of MYST/Esa1-associated factor 6 and PHF1 in endometrial stromal sarcoma.
    Panagopoulos I; Micci F; Thorsen J; Gorunova L; Eibak AM; Bjerkehagen B; Davidson B; Heim S
    PLoS One; 2012; 7(6):e39354. PubMed ID: 22761769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MEAF6/PHF1 is a recurrent gene fusion in endometrial stromal sarcoma.
    Micci F; Gorunova L; Gatius S; Matias-Guiu X; Davidson B; Heim S; Panagopoulos I
    Cancer Lett; 2014 May; 347(1):75-8. PubMed ID: 24530230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Malignant perivascular epithelioid cell neoplasm (PEComa) of the urinary bladder with TFE3 gene rearrangement: clinicopathologic, immunohistochemical, and molecular features.
    Williamson SR; Bunde PJ; Montironi R; Lopez-Beltran A; Zhang S; Wang M; Maclennan GT; Cheng L
    Am J Surg Pathol; 2013 Oct; 37(10):1619-26. PubMed ID: 23797724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A distinctive subset of PEComas harbors TFE3 gene fusions.
    Argani P; Aulmann S; Illei PB; Netto GJ; Ro J; Cho HY; Dogan S; Ladanyi M; Martignoni G; Goldblum JR; Weiss SW
    Am J Surg Pathol; 2010 Oct; 34(10):1395-406. PubMed ID: 20871214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Xp11 neoplasm with melanocytic differentiation of the prostate harbouring the novel NONO-TFE3 gene fusion: report of a unique case expanding the gene fusion spectrum.
    Wang XT; Xia QY; Ni H; Wang ZY; Ye SB; Li R; Wang X; Lv JH; Shi SS; Ma HH; Lu ZF; Shen Q; Zhou XJ; Rao Q
    Histopathology; 2016 Sep; 69(3):450-8. PubMed ID: 26844676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.